Timothy Wang, MD, and Kelley Yan, MD, PhD, have each been awarded 2022 Annual Recognition Prizes from the American Gastroenterological Association (AGA).
In a new content series, Notes from the Lab, we spotlight research by the Piero Dalerba lab that aims to predict resistance to immunotherapy in certain colon cancers.
Having a rapport with kids is a critical part of the job for Dr. James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
In the early days of Columbia's cancer program, these incredible women physicians and scientists made key discoveries in the field of cancer research and medicine.
As one of the early pioneers of surgical pathology, Dr. Frantz made a series of important cancer discoveries, including key studies of the surgical pathology of insulin-secreting pancreatic tumors.
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
A distinguished leader in surgery, medicine, and academia, Dr. Forde applied a strong but gentle approach to enacting change during his longstanding career.
In a new study, researchers demonstrate that applying artificial intelligence to standard-of-care imaging can help predict how well immunotherapy will work for patients with melanoma.
